Therefore, functional inhibition of key inflammatory cytokines, such as IL-6, IL-1β, and/or IL-17, which are critical for the development of pathogenic T cell responses and viral persistence, may prevent the pathogenesis of TMEV-induced demyelinating disease. The gene discussed is IL6; the disease is demyelinating disease.